Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06323980 · ClinicalTrials.gov registry record · NA

INHANCE Stemless Reverse Shoulder IDE

A NA study of Arthroplasty and Shoulder, sponsored by DePuy Orthopaedics.

Recruiting
Registry status
NA
Development phase
168
Enrollment target
18
Study locations

NCT06323980: Recruiting NA study of Arthroplasty and Shoulder, sponsored by DePuy Orthopaedics.

NCT06323980 is a NA study of Arthroplasty and Shoulder that is actively recruiting participants, run by DePuy Orthopaedics. The registered enrollment target is 168 participants, below the 208-participant average among 5 other Arthroplasty trials with a reported enrollment target (19% lower). The trial reports 18 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06323980, a NA study of Arthroplasty and Shoulder, is actively recruiting participants, sponsored by DePuy Orthopaedics.

RECRUITING
Registry status
NA
Development phase
168 participants
Enrollment target
18
Study locations

Study Summary

2:1 Randomized, Controlled, Multi-Center, Prospective, Pre-Market Study of the INHANCE Stemless Reverse Cementless Total Shoulder.

Primary Outcome

Primary effectiveness endpoint - Adjusted Constant-Murley Change from Baseline (ACM CFB) at 2 years post-operative. The CMS is a 100 point scale, the higher the score, the higher the quality of the function. ACM will be obtained by dividing the raw score by the relative score.

Interventions

  • DEVICE Reverse Total Shoulder

Study Locations (18)

Ohio

  • Crystal Clinic Orthopaedic Center - Akron
  • Lindner Research Center - Cincinnati
  • Cleveland Clinic - Cleveland

California

  • Hoag Orthopedic Institute - Irvine
  • Cedars Sinai Medical Center - Los Angeles

North Carolina

  • OrthoCarolina Research Institute Charlotte - Charlotte
  • Duke Orthopaedics of Raleigh - Raleigh

Pennsylvania

  • St. Luke's University Health Network - Bethlehem
  • Rothman Orthopaedics Institute - Philadelphia

Utah

  • TOSH- The Orthopedic Specialty Hospital - Murray
  • University of Utah - Salt Lake City

Florida

  • Orthopedic Center of Palm Beach County - Atlantis

Massachusetts

  • Boston Bone & Joint Institute BBJI Formerly BSSC - Waltham

Michigan

  • Trinity Health Grand Rapids - Grand Rapids

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2025-03-04
Est. Completion 2028-09-29
Phase NA
DePuy Orthopaedics

38 total trials

What NCT06323980 shows while recruiting

NCT06323980 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 208-participant average among 5 other Arthroplasty trials with a reported enrollment target (19% lower).

The record links to 3 conditions, with Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which Reverse Total Shoulder is the first listed.

NCT06323980 lists 18 locations in 12 states (Ohio, California, North Carolina).

Frequently Asked Questions

What is clinical trial NCT06323980 about?

NCT06323980 is a clinical study titled "INHANCE Stemless Reverse Shoulder IDE". 2:1 Randomized, Controlled, Multi-Center, Prospective, Pre-Market Study of the INHANCE Stemless Reverse Cementless Total Shoulder.

What is the current status of trial NCT06323980?

This trial is currently recruiting. It is a NA study. The enrollment target is 168 participants. The study started on 2025-03-04. Estimated completion is 2028-09-29.

What conditions does trial NCT06323980 study?

This clinical trial studies the following conditions: Arthroplasty, Shoulder, Replacement.

What interventions are being tested in trial NCT06323980?

The interventions under investigation include: Reverse Total Shoulder (DEVICE).

Who is sponsoring clinical trial NCT06323980?

This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06323980 being conducted?

This trial has 18 study locations across California, Florida, Massachusetts, Michigan, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02118922 · 168 participants

    A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

  • NCT03536897 · 168 participants

    IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry

  • NCT04078230 · 168 participants · NA

    Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

  • NCT04159168 · 168 participants · NA

    Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06323980, the US trial registry maintained by the National Library of Medicine. NCT06323980 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.